Candriam S.C.A. Moderna, Inc. Transaction History

Candriam S.C.A.

$16.8 Billion
Q2 2025

A detailed history of Candriam S.C.A. transactions in Moderna, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 220,986 shares of MRNA stock, worth $5.89 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

220,986

Previous 281,946 21.62%

Holding current value

$5.89 Million

Previous $7.99 Million 23.72%

% of portfolio

0.04%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$23.65 - $28.54 $1.44 Million - $1.74 Million	-60,960 Reduced 21.62%	220,986 $6.1 Million
Q1 2025 May 14, 2025	SELL	$28.35 - $47.53 $9.38 Million - $15.7 Million	-330,916 Reduced 54.0%	281,946 $7.99 Million
Q4 2024 Feb 06, 2025	SELL	$36.85 - $63.93 $545,527 - $946,419	-14,804 Reduced 2.36%	612,862 $25.5 Million
Q3 2024 Nov 13, 2024	BUY	$63.64 - $125.14 $9.27 Million - $18.2 Million	145,614 Added 30.21%	627,666 $41.9 Million
Q2 2024 Aug 05, 2024	BUY	$101.21 - $166.61 $4.05 Million - $6.67 Million	40,007 Added 9.05%	482,052 $57.2 Million
Q1 2024 May 03, 2024	BUY	$85.37 - $115.44 $6.74 Million - $9.12 Million	79,001 Added 21.76%	442,045 $47.1 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $5.51 Million - $8.28 Million	-79,316 Reduced 17.93%	363,044 $36.1 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $8.89 Million - $11.7 Million	92,221 Added 26.34%	442,360 $45.7 Million
Q2 2023 Aug 08, 2023	SELL	$118.5 - $160.53 $6.88 Million - $9.32 Million	-58,055 Reduced 14.22%	350,139 $42.5 Million
Q1 2023 May 12, 2023	SELL	$135.66 - $197.02 $1.62 Million - $2.35 Million	-11,933 Reduced 2.84%	408,194 $62.7 Million
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $20.6 Million - $36.6 Million	174,228 Added 70.85%	420,127 $75.5 Million
Q3 2022 Nov 10, 2022	BUY	$118.07 - $194.18 $13 Million - $21.4 Million	110,425 Added 81.51%	245,899 $29.1 Million
Q2 2022 Aug 03, 2022	BUY	$117.13 - $176.59 $611,887 - $922,506	5,224 Added 4.01%	135,474 $19.4 Million
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $4.93 Million - $9.17 Million	-39,014 Reduced 23.05%	130,250 $22.4 Million
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $8.87 Million - $14.5 Million	-39,291 Reduced 18.84%	169,264 $43 Million
Q3 2021 Nov 09, 2021	SELL	$221.9 - $484.47 $21.8 Million - $47.7 Million	-98,459 Reduced 32.07%	208,555 $80.3 Million
Q2 2021 Jul 20, 2021	SELL	$129.91 - $234.98 $11.6 Million - $20.9 Million	-89,153 Reduced 22.5%	307,014 $72.1 Million
Q4 2020 Jan 22, 2021	BUY	$65.74 - $169.86 $7.25 Million - $18.7 Million	110,333 Added 38.6%	396,167 $41.4 Million
Q2 2020 Jul 23, 2020	BUY	$29.67 - $80.0 $8.48 Million - $22.9 Million	285,834 New	285,834 $18.6 Million

Others Institutions Holding MRNA

# of Institutions

861

Shares Held

266M

Call Options Held

28.5M

Put Options Held

34.9M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $10.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account